8,9-EET, 11,12-EET, and 14,15-EET. Each EET regioisomer is quickly hydrolyzed by epoxide hydrolase into four dihydroxyeicosatrienoic acids (DHETs). [6, 7] Cyclooxygenases metabolize AA to synthesize prostacyclin (PGI 2 ) which is rapidly converted non-enzymatically to biologically inactive 6-keto-prostaglandin F1α (6-keto-PGF1α). [8] AA is also converted by lipoxygenase into leukotrienes and 12-hydroxyeicosatetraenoic acid (12-HETE). EETs and PGI 2 are potent vasodilators by activation of the large conductance Ca 2+ -activated K + channels and attenuation of intracellular Ca 2+ concentration in vascular smooth muscle cells. [9] [10] [11] The effects of 12-HETE on vasoreactivity are more complex and dependent on species and vessel beds. For instance, 12-HETE can dilate the porcine coronary artery [11] but constricts the canine renal arcuate artery. [12] It has been shown that a reduction of PGI 2 biosynthesis was related to diabetic vascular dysfunction [13] and an increase of 12-HETE generation was observed in diabetic patients with early renal disease. [14] However, the correlation between AA metabolites and vascular dysfunction in diabetic patients, particularly in Chinese elderly with type 2 diabetes, has not been investigated. In this study, we carried out a case-control study that enrolled 60 healthy elderly volunteers, 78 SD patients without nephropathy, and 58 SD patients with diagnosed nephropathy. We found that endothelium-dependent and -independent vasodilation in the brachial artery was impaired, which was accompanied by decreased EET and PGI 2 production in diabetic patients. Diabetic brachial artery dysfunction was correlated with 14,15-DHET before the development of nephropathy. Most importantly, there was a strong negative correlation between brachial artery function and urinary albumin excretion (UAE) in diabetic patients with nephropathy. Hence, serum 14,15-DHET could serve a biological marker for the evaluation of vascular function and a warning sign of renal microvascular dysfunction in SD patients.
mEthods

Subjects
A case-control study was conducted with Han Chinese patients with type 2 DM in our hospitals during 2007-2010. Type 2 diabetes and diabetic nephropathy were diagnosed according to the American Diabetes Association Diagnostic Criteria (1997). Patients were split into two groups according to their renal function: SD patients without nephropathy (SD) and SD patients with nephropathy (SDN). Patients with primary kidney diseases, heart failure, stroke, coronary artery disease, severe hypertension, and arterial thrombotic diseases were excluded in order to avoid potential confounding factors. Seventy-eight SD patients (39 males and 39 females, ages of 60-78 years) and 58 SDN patients (30 males and 28 females with 60-80 years of age) were recruited. Age-matched volunteers (30 males and 30 females, ages of 60-70 years) free of systemic diseases known to affect vascular or endothelial function, such as coronary artery disease, stroke, diabetes, hypertension, hyperlipidemia, cancer, inflammatory disease, active infection, and trauma during at least 3 years of continuous physical examination in our hospital served as healthy controls. The study protocol was approved by the Medical Ethics Review Board of the Shanghai Public Health Bureau, and a written informed consent was obtained from all participants before their participation in the study.
Laboratory examinations
Blood samples were obtained using the standard sterile technique from the antecubital vein. Serum triglyceride (TG) (enzymatic colorimetric method), total cholesterol (TC) (enzymatic colorimetric method), fasting blood glucose (hexokinase method), and hemoglobin A1c (HbA1c) (high-performance liquid chromatography) were measured using a Hitachi Clinical Analyzer 7600 (Hitachi, High-Technologies Co., Japan).
A 24-h urine collection test was performed. UAE was given as the mean of 24-h urine excretions and glomerular filtration rate (GFR) was estimated by 24-h creatinine clearance. Diabetic nephropathy was defined as microalbuminuria ( U A E : 3 0 -3 0 0 m g / 2 4 h ) o r m a c r o a l b u m i n u r i a (UAE >300 mg/24 h), respectively, proteinuria >0.5 g/24 h and/or GFR <60 mL/min/1.73 m, based on the guidelines of the American Diabetes Association. [15] The concentrations of fasting serum 14,15-EET and 6-keto-PGF1α were measured using ELISA kits purchased from Detroit R and D Inc. (Detroit, USA) and Cayman Chemical Co. (Ann Arbor, USA), respectively.
Flow-mediated dilation (FMD) and nitroglycerine-induced dilation (NID): FMD. [16] At least 5 h after fasting, patients were required to lie at rest for 15 min at room temperature (22°C) and FMD was assessed using a Vivid 7.0.4 Ultrasound System (GE healthcare Co., USA) with a 14-Hz linear transducer. The right brachial artery at 2.0-2.5 cm above the elbow was scanned laterally. The average internal diameter at end-diastole (D 0 ) was measured and calculated from three cardiac cycles. Subsequently, the pneumatic cuff was inflated at 30 mmHg above systolic blood pressure for 5 min, rapidly released to 0 mmHg, and the end-diastolic arterial diameter (D 1 ) was measured within 1 min. After a 15-min rest, 0.5 mg nitroglycerin (NTG) was administrated sublingually to assess endothelium-independent vasodilation (NID). Arterial diameter (D 2 ) was measured at 5 min after NTG administration. FMD and NID were calculated as [
Statistical analysis
Data are presented as mean ± standard deviation ±. Statistical analyses were performed using PASW Statistics for Windows, version 18.0 (SPSS Inc., Chicago, IL, USA). One-way analysis of variance (ANOVA) was used to compare the differences among the three groups. Kruskal-Wallis post hoc test was applied for pairwise comparison whenever the main effect of ANOVA was significant. Spearman's rank correlation test was used to determine the correlation between two variables. Statistical significance was defined as P < 0.05.
rEsults
The gender distribution was similar amongst the three groups. The mean age of participants was 67.0 years (n = 60) in health elderly, 68.3 years (n = 78, P = N.S. vs. health elderly and SDN) in SD and 70.5 years (n = 58, P < 0.05 vs. health elderly and P = N.S. vs. DM) in SDN group. The duration of diabetic diagnosis was 7.7 years in the SD group and 16.9 years (P < 0.05 vs. SD) in the SDN group. Half of the SD patients developed nephropathy within 9 years after the diagnosis of diabetes, similar to a previous report.
[ 17] In healthy elderly controls, serum TC, TG, HbA1c, FPF, and UAE levels were within normal ranges. SD patients had a significantly decreased FPF and increased UAE in 24-h urine collection, compared to healthy elderly controls. Moreover, FPF and UAE were exacerbated in SDN patients [ Table 1 ]. Serum TG, TC, and HbA1c were significantly elevated in SD patients, accompanied by a remarkable reduction of serum 14,15-DHET and 6-keto-PGF1α production, compared to those in healthy elderly controls. Moreover, SDN patients had a worsened lipid profile and a poor glycemic control as shown in Table 1 .
Brachial arterial diameter at baseline, cuff release and after a 5-min sublingual administration of 0.5 mg NTG is illustrated in Table 2 . There was no significant difference in baseline brachial artery inner diameter amongst the three study groups. FMD and NID in the brachial artery were remarkably reduced in SD patients (P < 0.05 vs. healthy elderly controls). However, there was no further decline in SDN patients. These results may suggest that impaired endothelium-dependent and -independent vasodilation in the brachial artery may precede the onset of diabetic nephropathy in diabetic patients.
Multiple regression analysis demonstrated that in healthy elderly controls, FMD was positively correlated with 6-keto-PGF1α, but not with 14,15-DHET, TG, TC, and HbA1c [ Table 3 ]. In addition, NID was negatively correlated with FMD, which may be explained by the limitation of maximal dilation of the vessel. In SD patients, the correlation of FMD with 14,15-DHET and 6-keto-PGF1α was lost, but that of NID with 14,15-DHET and 6-keto-PGF1α was remained [ Table 4 ]. In SDN patients, similarly, neither correlation between FMD and 14,15-DHET or 6-keto-PGF1α was distinguished, nor was NID with 14,15-DHET. However, the correlation between NID and 6-keto-PGF1α was observed in SDN patients [ Table 5 ]. Serum 14,15-DHET and 6-keto-PGF1α levels were negatively correlated with HbA1c, TG, TC, and UAE, but varied with different stages of the disease [ Tables 4 and 5 ]. There were a strong negative correlation between UAE and NID and a strong positive correlation between UAE and TG in SDN patients.
discussion
Cyclooxygenases are abundantly expressed in both endothelial cells and smooth muscle cells in the vasculature, while CYP epoxygenases are mainly expressed in vascular endothelial cells. [18, 19] As EDRFs, roles of EETs and PGI 2 on the endothelium-dependent vasodilation have been extensively investigated. EET and PGI 2 directly activate vascular potassium channels, resulting in the closure of voltage-gated Ca 2+ channels, reduction of intracellular Ca 2+ concentration, and vascular relaxation. [18, 20] It has been shown that PGI 2 and EET biosynthesis was down-regulated in diabetic rats. [20, 21] Pharmacological increase of EET and PGI 2 generations improved renal function in diabetic mice. [22, 23] Clinical studies also demonstrated that long-term administration of PGI 2 -protected renal function in diabetic patients. [24] Up to date, very little is known about EET biosynthesis and its relationship with vascular dysfunction in diabetes, practically in senile human subjects with type 2 diabetes. Recently, a study has shown that genetic variation of CYP epoxygenases was associated with the early onset of human type 2 diabetes. [25] In this study, we found that both FMD and NID in brachial artery were diminished, accompanied by a remarkable reduction in serum 14,15-DHET and 6-keto-PGF1α levels in senile Chinese patients diagnosed with type 2 diabetes. Furthermore, serum 14,15-DHET level was positively correlated with serum 6-keto-PGF1α in SD patients, but negatively correlated with HbA1c and TC in SD patients. It makes more sense to our knowledge that an increase of EET and PGI 2 biosynthesis and decrease of blood glucose and TC are beneficial to diabetic patients.
FMD is a commonly used methodology for evaluating the endothelium-dependent vasodilation. We found that FMD in brachial artery occurred only in healthy elderly but not in diabetic patients, while NID in brachial artery was remained in diabetic patients. These results may imply that the endothelium-dependent brachial artery vasodilation was impaired and its role was compensated by the endothelium-independent mechanism in SD patients. Interestingly, NID was independently correlated with 14,15-DHET in diabetic patients before the development of nephropathy, and such correlation was lost in the patients with nephropathy. On the other hand, the correlation between 6-keto-PGF1α and NID lasted during the stage of diabetic nephropathy. We believe that these differences may account for biosynthesis ability or protein expression of CYP and COX-2 enzymes in the vasculature of participants. Since diabetic patients with nephropathy had a longer duration of the disease in this study, our results may also suggest that EET-associated vasodilation in diabetes exists only a certain period before total loss of endothelium function. It is worth noting that UAE was strong negatively correlated with NID, suggesting that there is severe microvascular dysfunction in the kidney.
CYP epoxygenases are abundantly expressed in vasculature and kidney. [26] Animal studies have shown the protective effects of EETs on renal function in rats. [27] The increase of CYP epoxygenase expression attenuated nephropathy in diabetic mice. [22] Since renal dysfunction and cardiovascular complication have higher mortality and worsened clinical outcomes, [28] serum 14,15-DHET level could serve an early market for the evaluation of vascular function and a warning sign for diabetic renal dysfunction in diabetic patients.
